A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without ...

In a recent video on Instagram, Dr. Joseph Salhab, an expert in digestion, liver, pancreas & nutrition talked about science-backed vegetables that naturally strengthen the liver.

Liver enzymes help the liver perform these functions by speeding up chemical reactions. Elevated liver enzymes happen when there are higher-than-normal levels of liver enzymes in your blood.

Brian Johnson a.k.a. The Liver King met his wife in 2004 and the two got married four months later. Here’s everything to know about controversial influencer Johnson's wife, Bozena “Barbara ...

The condition, called severe metabolic-dysfunction-associated fatty liver disease (), affects more than 1 in 4 adults worldwide.Once known as nonalcoholic fatty liver disease, it can lead to ...

Rocky Hill-based Nutmeg State Financial Credit Union and Hamden-based CrossPoint Federal Credit Union announced Monday plans to merge. The combined entity would run under the Nutmeg brand and ...

Adult patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or advanced liver fibrosis showed improved liver histology with a once-weekly dose of semaglutide (Wegovy ...

Even if you’re in good health, eating a liver-protective diet is a smart habit to adopt for long-lasting metabolic function and energy. Foods good for liver health become especially important ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared with placebo. News. All News Press Releases Product Approvals and Launches.

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.